-
Beyond the logistical disincentives, hassles and headaches of reporting to employee health after an injury in the operating room there is the chilling stigma of what the surgeon may find out about herself and possibly be obligated to tell future patients: "I'm HIV-positive."
-
Veteran surgeon Ramon Berguer, MD, routinely stitches up patients in suture seams as tight as a quarter-inch or less, with the needle tip drawing perilously close to his gloved opposite hand. Occasionally it hits with the force to cause a needlestick, but what results is not an injury but a memory.
-
Though a growing sense of public apathy threatens to reduce H1N1 influenza A to the Rodney Dangerfield of pandemics, those who have experienced or witnessed a severe case of infection will not soon forget this erstwhile "swine flu."
-
Infection preventionists recently received some legal advice, and it wasn't quite as bleak as the old admonition to put everything you own under your spouse's name.
-
The Occupational Safety and Health Administration's compliance directive to protect health care workers from H1N1 pandemic influenza A includes a series of questions inspectors may ask when on a health care site visit. Know the answers to these and you're OSHA ready in terms of H1N1:
-
You might receive a citation from the Occupational Safety and Health Administration (OSHA) if you fail to assess respiratory hazards related to H1N1 pandemic influenza A, don't use various methods to reduce employee exposure or fail to consider respirators other than N95s when there is a shortage.
-
The American College of Surgeons (ACS) most recent recommendations on infection prevention and safety in the operating room are summarized as follows:
-
Screening STD clinic patients especially men who have sex with men (MSM) for signs of an acute, highly transmissable stage of HIV infection could heighten detection and prevention efforts, the Centers for Disease Control and Prevention.
-
Fatigue is such a common complaint among HIV patients that it's often ignored or expected in clinical care.
-
On Nov. 5, 2009, using expedited review procedures developed to support the President's Emergency Program For AIDS Relief (PEPFAR), the Food and Drug Administration (FDA), granted tentative approval for lamivudine and tenofovir disoproxil fumarate fixed dose combination tablets, 300mg/300mg.
